Weight management program for Chinese cancer survivors
Part of Cancer, Hormones & metabolism clinical trials.
This trial is for Chinese cancer survivors who are overweight. It offers a weight management program to help you live healthier after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are of Chinese ethnicity.
- You speak Cantonese or Mandarin.
- You are 18 years old or older.
- You had early-stage cancer (stage 0, I, or II).
- You have finished all main cancer treatments (like chemo and radiation).
- Your BMI is 23 or higher (considered overweight in Asian populations).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program called FitARise that helps cancer survivors start an exercise routine. It uses a simple 3-step plan to guide you through safe physical activity after treatment.
This trial tests a lifestyle and behavior program to help breast cancer survivors manage overweight or obesity. It may help you improve your weight and overall health after cancer treatment.
This study tests two different smartphone-based programs to help young adult cancer survivors lose weight. Participants are randomly assigned to one of two programs and use an app to track their progress.
This trial tests a support program designed to improve quality of life for Chinese cancer patients and survivors. If you qualify, you'll join the program by phone or video call.
This study tests a weight loss program designed specifically for women who have finished breast cancer treatment. It aims to help improve overall health after cancer.
This trial uses a mobile chat service to provide exercise advice for older adults who have finished cancer treatment. It aims to help you become more active and feel better after cancer.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.